unknown
Stage
About
Werewolf Therapeutics develops conditionally activated immunotherapies designed to selectively stimulate the immune system within the tumor microenvironment for cancer treatment while limiting off-target effects.
Explore Werewolf Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.